Another property to take into consideration in the treatment of cancer is the modulation of phase II detoxifying enzymes such as glutathione-s-transferase and quinone oxidoreductase, which protect cells from xenobiotic agents, oxidants and secondary metabolites that are toxic to cells. The gene discussed is CRYZ; the disease is cancer.